These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Unfractionated heparin and low molecular weight heparin for acute coronary syndromes--assessment of a Cochrane review]. Husted SE; Nielsen HK Ugeskr Laeger; 2010 Sep; 172(37):2522-6. PubMed ID: 20836961 [TBL] [Abstract][Full Text] [Related]
8. [Comparison of therapeutic efficacy between fondaparinux and low molecular weight heparin for patients with acute coronary syndrome]. Wang QK; Guo M; Zhang YQ; Song Y Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Oct; 22(10):628-31. PubMed ID: 20977850 [TBL] [Abstract][Full Text] [Related]
10. Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: a systematic review and meta-analysis. Galli M; Andreotti F; D'Amario D; Vergallo R; Vescovo GM; Giraldi L; Migliaro S; Ameri P; Porto I; Crea F Eur Heart J Cardiovasc Pharmacother; 2020 Jan; 6(1):43-56. PubMed ID: 31350546 [TBL] [Abstract][Full Text] [Related]
11. Current anticoagulation options in percutaneous intervention: designing patient-specific strategies. French MH; Faxon DP Rev Cardiovasc Med; 2002; 3(4):176-82. PubMed ID: 12556751 [TBL] [Abstract][Full Text] [Related]
12. Current update on glycoprotein IIb-IIIa and direct thrombin inhibition in percutaneous coronary intervention for non-ST elevation acute coronary syndromes: balancing bleeding risk and antiplatelet efficacy. Kwa AT; Rogers JH J Interv Cardiol; 2008 Apr; 21(2):107-17. PubMed ID: 18248357 [TBL] [Abstract][Full Text] [Related]
13. Antiplatelet intervention in acute coronary syndrome. Arora RR; Rai F Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648 [TBL] [Abstract][Full Text] [Related]
14. Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials. Mehta SR; Boden WE; Eikelboom JW; Flather M; Steg PG; Avezum A; Afzal R; Piegas LS; Faxon DP; Widimsky P; Budaj A; Chrolavicius S; Rupprecht HJ; Jolly S; Granger CB; Fox KA; Bassand JP; Yusuf S; Circulation; 2008 Nov; 118(20):2038-46. PubMed ID: 18955665 [TBL] [Abstract][Full Text] [Related]
15. Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention. Wong GC; Giugliano RP; Antman EM JAMA; 2003 Jan; 289(3):331-42. PubMed ID: 12525234 [TBL] [Abstract][Full Text] [Related]
16. The use of antithrombotics for acute coronary syndromes in the emergency department: considerations and impact. Mukherjee D; Eagle KA Prog Cardiovasc Dis; 2007; 50(3):167-80. PubMed ID: 17976502 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of indigenously developed and manufactured bivalirudin in moderate/high-risk Indian patients undergoing percutaneous coronary intervention: the Bivaflo Registry. Seth A; Sinha N; Parikh K; Patel T; Hiremath MS; Mehta AB; Chandra P; Pinto B; Sethi KK; Sengottuvelu S Indian Heart J; 2008; 60(4):333-41. PubMed ID: 19242012 [TBL] [Abstract][Full Text] [Related]
18. Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold? Huber K; Bates ER; Valgimigli M; Wallentin L; Kristensen SD; Anderson JL; Lopez Sendon JL; Tubaro M; Granger CB; Bode C; Ohman EM; Steg PG Am Heart J; 2014 Nov; 168(5):611-21. PubMed ID: 25440788 [TBL] [Abstract][Full Text] [Related]
19. Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors. Bangalore S; Toklu B; Kotwal A; Volodarskiy A; Sharma S; Kirtane AJ; Feit F BMJ; 2014 Nov; 349():g6419. PubMed ID: 25389143 [TBL] [Abstract][Full Text] [Related]
20. Comparison of low molecular weight heparin with unfractionated heparin during percutaneous coronary interventions: a meta-analysis. Kodumuri V; Adigopula S; Singh P; Swaminathan P; Arora R; Khosla S Am J Ther; 2011 May; 18(3):180-9. PubMed ID: 20027109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]